Dermatitis

• FDA approval · 2009-09-04
  FDA Approved: HYDROCORTISONE BUTYRATE — Supplemental Application (Oceanside Pharmaceuticals)

  FDA approved a supplemental application for hydrocortisone butyrate by Oceanside Pharmaceuticals. This indicates an approved change to the p…

• FDA approval · 2009-07-30
  FDA Approved: ALCLOMETASONE DIPROPIONATE — Original Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved Glenmark's alclometasone dipropionate for topical use via an original ANDA, enabling a generic topical corticosteroid product.

• FDA approval · 2009-05-26
  FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  The FDA approved a supplemental application for Betamethasone Dipropionate from Sun Pharmaceutical Industries, granting approval of a generi…

• FDA approval · 2008-09-23
  FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Glenmark Pharmaceuticals Inc., USA)

  The FDA approved Glenmark's original ANDA for topical betamethasone dipropionate, a generic corticosteroid, for inflammatory skin conditions…

• FDA approval · 2008-03-31
  FDA Approved: HYDROXYZINE HYDROCHLORIDE — Original Application (Northstar RxLLC)

  FDA approved Northstar RxLLC's Original Application for hydroxyzine hydrochloride, a generic antihistamine product.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2008-03-25
  FDA Approved: CORDRAN — Supplemental Application (INA Pharmaceutics, Inc)

  The FDA approved a supplemental application for Cordran (flurandrenolide) from INA Pharmaceutics, Inc.

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles

  A completed clinical trial evaluated digital imaging as a diagnostic aid for psoriasis, dermatitis, and nevi (moles). The study aimed to det…

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal Volunteers

  A status update on a clinical trial investigating suction blister induction in participants including those with dermatitis, urticaria, vesi…

• FDA label_change · 2007-12-12
  FDA Approved: DERMOTIC — Supplemental Application (Royal Pharmaceuticals)

  FDA approved a supplemental application for DERMOTIC (fluocinonide acetate) submitted by Royal Pharmaceuticals, typically resulting in updat…

• FDA approval · 2007-09-04
  FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  The FDA approved a supplemental application for a generic topical product combining nystatin and triamcinolone acetonide (Sun Pharmaceutical…

• FDA approval · 2007-05-21
  FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)

  FDA approved the original application for Betamethasone Dipropionate (a generic topical corticosteroid) from E. Fougera & Co., marking appro…

• FDA approval · 2007-05-21
  FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved a generic topical corticosteroid, Betamethasone Dipropionate, under Sun Pharmaceutical Industries' Original Application.

• FDA approval · 2006-08-28
  FDA Approved: DIPROLENE — Supplemental Application (Organon LLC)

  FDA approved a supplemental application for Diprolene (betamethasone dipropionate) submitted by Organon LLC, resulting in updated labeling f…

• FDA approval · 2006-08-14
  FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.)

  FDA approves a supplemental application for clobetasol propionate from E. Fougera & Co. (division of Fougera Pharmaceuticals Inc.), under th…